[1]
O. Karem and K. Hamza, “ASSESSMENT OF ANTICOAGULANT DRUGS IN ELIGIBLE PATIENTS WITH ATRIAL FIBRILLATION”, JSMC, vol. 8, no. 3, pp. 199–204, Oct. 2018, doi: 10.17656/jsmc.10169.